Literature DB >> 34811469

Astrocytes modulate extracellular neurotransmitter levels and excitatory neurotransmission in dorsolateral striatum via dopamine D2 receptor signaling.

Louise Adermark1,2, Oona Lagström3, Anna Loftén3,4, Valentina Licheri3, Amy Havenäng3, Eleonora Anna Loi3, Rosita Stomberg3, Bo Söderpalm3,4, Ana Domi3, Mia Ericson3.   

Abstract

Astrocytes provide structural and metabolic support of neuronal tissue, but may also be involved in shaping synaptic output. To further define the role of striatal astrocytes in modulating neurotransmission we performed in vivo microdialysis and ex vivo slice electrophysiology combined with metabolic, chemogenetic, and pharmacological approaches. Microdialysis recordings revealed that intrastriatal perfusion of the metabolic uncoupler fluorocitrate (FC) produced a robust increase in extracellular glutamate levels, with a parallel and progressive decline in glutamine. In addition, FC significantly increased the microdialysate concentrations of dopamine and taurine, but did not modulate the extracellular levels of glycine or serine. Despite the increase in glutamate levels, ex vivo electrophysiology demonstrated a reduced excitability of striatal neurons in response to FC. The decrease in evoked potentials was accompanied by an increased paired pulse ratio, and a reduced frequency of spontaneous excitatory postsynaptic currents, suggesting that FC depresses striatal output by reducing the probability of transmitter release. The effect by FC was mimicked by chemogenetic inhibition of astrocytes using Gi-coupled designer receptors exclusively activated by designer drugs (DREADDs) targeting GFAP, and by the glial glutamate transporter inhibitor TFB-TBOA. Both FC- and TFB-TBOA-mediated synaptic depression were inhibited in brain slices pre-treated with the dopamine D2 receptor antagonist sulpiride, but insensitive to agents acting on presynaptic glutamatergic autoreceptors, NMDA receptors, gap junction coupling, cannabinoid 1 receptors, µ-opioid receptors, P2 receptors or GABAA receptors. In conclusion, our data collectively support a role for astrocytes in modulating striatal neurotransmission and suggest that reduced transmission after astrocytic inhibition involves dopamine.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34811469      PMCID: PMC9206030          DOI: 10.1038/s41386-021-01232-x

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  85 in total

1.  Electrophysiological properties and gap junction coupling of striatal astrocytes.

Authors:  Louise Adermark; David M Lovinger
Journal:  Neurochem Int       Date:  2008-03-04       Impact factor: 3.921

2.  Astrocytes shape the plastic response of adult cortical neurons to vision loss.

Authors:  Maroussia Hennes; Nathalie Lombaert; Jérôme Wahis; Chris Van den Haute; Matthew G Holt; Lutgarde Arckens
Journal:  Glia       Date:  2020-04-01       Impact factor: 7.452

3.  Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST.

Authors:  Rose-Marie Karlsson; Louise Adermark; Anna Molander; Stephanie Perreau-Lenz; Erick Singley; Matthew Solomon; Andrew Holmes; Kohichi Tanaka; David M Lovinger; Rainer Spanagel; Markus Heilig
Journal:  Neuropharmacology       Date:  2012-02-09       Impact factor: 5.250

4.  Hyperactivity with Disrupted Attention by Activation of an Astrocyte Synaptogenic Cue.

Authors:  Jun Nagai; Abha K Rajbhandari; Mohitkumar R Gangwani; Ayaka Hachisuka; Giovanni Coppola; Sotiris C Masmanidis; Michael S Fanselow; Baljit S Khakh
Journal:  Cell       Date:  2019-04-25       Impact factor: 41.582

5.  Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate.

Authors:  B Hassel; H Bachelard; P Jones; F Fonnum; U Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  1997-11       Impact factor: 6.200

6.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization.

Authors:  P Calabresi; R Maj; A Pisani; N B Mercuri; G Bernardi
Journal:  J Neurosci       Date:  1992-11       Impact factor: 6.167

7.  Selective inhibition of glial cell metabolism in vivo by fluorocitrate.

Authors:  B Hassel; R E Paulsen; A Johnsen; F Fonnum
Journal:  Brain Res       Date:  1992-03-27       Impact factor: 3.252

Review 8.  Direct measurement of oxidative metabolism in the living brain by microdialysis: a review.

Authors:  H Ronald Zielke; Carol L Zielke; Peter J Baab
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

9.  Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill.

Authors:  Henry H Yin; Shweta Prasad Mulcare; Monica R F Hilário; Emily Clouse; Terrell Holloway; Margaret I Davis; Anita C Hansson; David M Lovinger; Rui M Costa
Journal:  Nat Neurosci       Date:  2009-02-08       Impact factor: 24.884

Review 10.  A Circuit-Based Information Approach to Substance Abuse Research.

Authors:  David M Lovinger; Christina M Gremel
Journal:  Trends Neurosci       Date:  2020-11-06       Impact factor: 13.837

View more
  1 in total

Review 1.  Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson's Disease.

Authors:  Eric A Bancroft; Rahul Srinivasan
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.